Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Sponsor: Mayo Clinic
Summary
This study examines how spinal cord stimulation (SCS) affects pain level and quality of life in patients experiencing chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a nerve problem and one of the potential side effects of chemotherapy that causes pain, numbness, tingling, swelling, or muscle weakness in different parts of the body. CIPN usually begins in the hands or feet and gets worse over time. SCS is a type of therapy that has proven to be effective in treating numerous non-malignant pain disorders including failed back surgery syndrome, refractory angina, limb ischemia, complex regional pain syndrome, and diabetic peripheral neuropathy. SCS may also be useful in patients with CIPN. This study evaluates how SCS affects pain and quality of life in patients undergoing spinal cord stimulation for CIPN.
Official title: A Prospective Observational Study Assessing Efficacy of 10-kHz Spinal Cord Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2022-04-14
Completion Date
2027-04-15
Last Updated
2026-02-02
Healthy Volunteers
No
Conditions
Interventions
Quality-of-Life Assessment
Complete quality of life assessment
Questionnaire Administration
Complete questionnaires
Spinal Cord Stimulation
Receive spinal cord stimulation therapy
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States